Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement

Royal College of Psychiatrists’ Psychopharmacology Committee; Samuel R. Chamberlain; Antonio Metastasio; Paul R. A. Stokes; David S. Baldwin; With additional input from:; Hamish  McAllister-Williams; Julia Sinclair; Michael Browning; Allan Young

Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement

Royal College of Psychiatrists’ Psychopharmacology Committee , Samuel R. Chamberlain, Antonio Metastasio, Paul R. A. Stokes, David S. Baldwin, With additional input from:, Hamish McAllister-Williams, Julia Sinclair, Michael Browning, Allan Young

Research output: Book/Report › Report

223 Downloads (Pure)

Original language	English
Place of Publication	London
Publisher	Royal College of Psychiatrists
Publication status	Published - 13 Jul 2020

Access to Document

Use of monoamine oxidase inhibitors in psychiatric practiceFinal published version, 651 KB

https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps03_20.pdf?sfvrsn=bc814c70_2

Cite this

Royal College of Psychiatrists’ Psychopharmacology Committee , Chamberlain, S. R., Metastasio, A., Stokes, P. R. A., Baldwin, D. S., With additional input from:, McAllister-Williams, H., Sinclair, J., Browning, M., & Young, A. (2020). Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement. Royal College of Psychiatrists. https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps03_20.pdf?sfvrsn=bc814c70_2

@book{0c13205f2a5e4e508b96de5cfdbc6b4d,

title = "Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement",

author = "{Royal College of Psychiatrists{\textquoteright} Psychopharmacology Committee} and Chamberlain, {Samuel R.} and Antonio Metastasio and Stokes, {Paul R. A.} and Baldwin, {David S.} and {With additional input from:} and Hamish McAllister-Williams and Julia Sinclair and Michael Browning and Allan Young",

year = "2020",

month = jul,

day = "13",

language = "English",

publisher = "Royal College of Psychiatrists",

address = "United Kingdom",

}

Royal College of Psychiatrists’ Psychopharmacology Committee , Chamberlain, SR, Metastasio, A, Stokes, PRA, Baldwin, DS, With additional input from:, McAllister-Williams, H, Sinclair, J, Browning, M & Young, A 2020, Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement. Royal College of Psychiatrists, London. <https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps03_20.pdf?sfvrsn=bc814c70_2>

TY - BOOK

T1 - Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement

AU - Royal College of Psychiatrists’ Psychopharmacology Committee

AU - Chamberlain, Samuel R.

AU - Metastasio, Antonio

AU - Stokes, Paul R. A.

AU - Baldwin, David S.

AU - With additional input from:

AU - McAllister-Williams, Hamish

AU - Sinclair, Julia

AU - Browning, Michael

AU - Young, Allan

PY - 2020/7/13

Y1 - 2020/7/13

M3 - Report

BT - Use of monoamine oxidase inhibitors in psychiatric practice - Position Statement

PB - Royal College of Psychiatrists

CY - London

ER -